Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | [3] Daratumumab Daratumumab,Hyaluronidase, Hyaluronidase (human recombinant) | [4] D04455
D04455
,D04456 , D06604 , D10777 | [1] CD38 CD38 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 |
| 2 | Recombinant Human Hyaluronidase (rHuPH20) | [1] Hyaluronidase (human recombinant) Hyaluronidase (human recombinant) | - | - | - | [1] 65 65 |
| 3 | Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV) | [1] Hyaluronidase (human recombinant) Hyaluronidase (human recombinant) | - | - | - | [1] 65 65 |